Reactive stroma and trastuzumab resistance in HER2-positive early breast cancer.
Sonnenblick A, Salmon-Divon M, Salgado R, Dvash E, Pondé N, Zahavi T, Salmon A, Loibl S, Denkert C, Joensuu H, Ameye L, Van den Eynden G, Kellokumpu-Lehtinen PL, Azaria A, Loi S, Michiels S, Richard F, Sotiriou C.
Sonnenblick A, et al. Among authors: zahavi t.
Int J Cancer. 2020 Jul 1;147(1):266-276. doi: 10.1002/ijc.32859. Epub 2020 Jan 22.
Int J Cancer. 2020.
PMID: 31904863